Slow lab turnaround times impact patient health, disrupt hospital workflows, and create hidden costs for healthcare providers. Here is how diagnostic delays affect the healthcare system, and what high-throughput labs are doing about it.
Why Speed in Lab Testing Matters More Than You Think
Every day, millions of lab tests determine critical health decisions, from diagnosing infections to managing chronic diseases. When those results take too long, the consequences extend beyond inconvenience.
Slow turnaround times (TATs) disrupt clinical workflows, delay diagnoses, increase costs, and in some cases put patient lives at risk. Speed and accuracy in diagnostic testing are interdependent. When delays happen, the entire healthcare system feels the impact.
Nexus Medical Labs works with healthcare organizations to improve lab workflows without sacrificing accuracy. This post covers the clinical, operational, and financial costs of slow TATs, and how modern labs are solving for them.
The Patient Impact: Delayed Diagnoses & Treatment
When a patient is waiting for lab results, that time is a window for early intervention. Slow TATs narrow that window, sometimes to zero.
Chronic Disease Management: In conditions like diabetes, timely monitoring is critical. Delays in acting on lab results push treatment decisions back. One retrospective study found that delaying treatment intensification by as little as six months was associated with a significantly increased risk of diabetic nephropathy (Kaewbut et al., Healthcare, 2022).
Cancer Screening: Delays in cancer diagnosis are consistently associated with higher mortality rates and lower cure rates, with patient-related, system-related, and tumor-related factors all contributing to gaps between abnormal results and treatment (Haddadi et al., Frontiers in Public Health, 2024).
Infectious Disease Control: Rapid TATs are especially important during outbreaks. A study evaluating SARS-CoV-2 testing platforms found that delayed turnaround times directly limited efforts to control pandemic spread, while faster platforms enabled quicker contact tracing and case management (Marquis et al., Journal of Medical Microbiology, 2021).
For bloodstream infections and sepsis, speed is often the difference between life and death. A 2025 meta-analysis of 31 studies found that rapid molecular diagnostic testing for bloodstream infections significantly reduced mortality risk compared to standard blood cultures (Rapszky et al., eClinicalMedicine, 2025). Faster results mean faster treatment, and faster treatment means better outcomes.
The Operational Burden: Costs & Inefficiencies
Slow TATs ripple through clinical operations in ways that go well beyond the lab itself.
Longer Hospital Stays: A 2022 retrospective cohort study of over 15,000 ED visits found that each additional minute of laboratory TAT was independently associated with an additional 0.32 minutes of emergency department length of stay. The lab stage, they found, is the primary driver of overall TAT and a direct lever for reducing ED crowding(Vrijsen et al., BMC Emergency Medicine, 2022).
Repeat Testing and Unnecessary Procedures: Prolonged TATs are associated with increased repeat testing, duplicated investigations, and delayed clinical decision-making (Dawande et al., Cureus, 2022). The cost of this waste is substantial: a large-scale analysis of Medicare and commercial payer data found that 23.8% of patients who were tested underwent excessive laboratory testing, with estimated excess Medicare expenditure of $1.95 to $3.28 billion in a single year (Smart et al., Archives of Pathology & Laboratory Medicine, 2025).
Disrupted Clinical Workflows: Delayed result awareness has been described as the largest contributor to therapeutic turnaround time in emergency settings. When physicians and nurses lack real-time notification of available results, they must repeatedly check systems manually, pulling time directly from patient care(Dawande et al., Cureus, 2022).
Fast TATs affect operational efficiency at every level of the healthcare system, not just in the lab.
The Business Cost: Revenue, Reputation, and Relationships
Beyond patient care, slow lab processing carries direct financial and competitive consequences.
Delayed Reimbursements: Lab results drive billing. When TATs are slow, documentation is incomplete, insurance claims are delayed, and cash flow suffers, particularly for high-volume providers with tight operating margins.
Client Retention: Healthcare providers choose lab partners based on consistency and reliability. Turnaround time is one of the primary metrics clinicians use to evaluate lab performance (Dawande et al., Cureus, 2022). Labs that fall short of expected TATs put those relationships at risk.
Patient Satisfaction: TAT is closely tied to patient satisfaction scores. Long wait times affect online reviews and referral patterns, influencing where patients seek care (Dawande et al., Cureus, 2022).
Nexus Medical Labs works with healthcare organizations to keep turnaround times consistent and reporting reliable.
Regulatory and Compliance Risks of Slow TATs
Labs that consistently miss TAT benchmarks face more than operational headaches.
Infectious Disease Reporting: Public health agencies require timely test results for outbreak surveillance. Delayed reporting can hinder containment and, in some cases, violate mandatory reporting requirements for notifiable conditions.
CLIA and CAP Compliance: CLIA and CAP accreditation standards include TAT requirements as part of laboratory quality management. Prolonged or inconsistent TATs can trigger deficiencies during inspection and, in severe cases, put accreditation at risk (Dawande et al., Cureus, 2022).
Lab compliance directly affects quality, accreditation, and client trust.
How High-Throughput Labs Solve the Turnaround Time Problem
Leading diagnostic labs are investing in automation, AI-driven processing, and optimized logistics to shrink TATs without adding headcount.
Total Laboratory Automation: A 2025 prospective study found that integrating full laboratory automation with automated blood culture loading, positive culture subculturing, and expert system result review, which significantly reduced time from collection to final report and improved clinical outcomes for patients with gram-negative bacteremia (Qin et al., Microbiology Spectrum, 2025). A separate 2026 comparison of automated versus manual urine culture workflows found automation reduced median TAT by nearly 15 hours (Khalid et al., Diagnostics, 2026).
AI-Assisted Result Flagging: Machine learning models integrated into lab information systems can prioritize critical samples, flag anomalies before reporting, and alert clinicians in real time, reducing the gap between result availability and clinical action.
Real-Time Logistics and Self-Collection: Efficient sample transportation and patient-friendly self-collection options both reduce pre-analytical delays. At-home self-collection in particular removes clinic scheduling as a bottleneck, and Nexus supports self-collected specimen processing across its testing menu.
Nexus specializes in supporting healthcare providers with efficient lab workflows, high-throughput sample processing, and fast, accurate reporting.
Future Trends: Faster, Smarter Diagnostics
The direction of laboratory medicine is clear: shorter TATs, tighter EHR integration, and wider access to rapid diagnostics.
Rapid Molecular Diagnostics: Point-of-care and near-patient molecular testing platforms are compressing TATs from days to hours. For bloodstream infections, rapid assays now achieve results in under 12 hours, compared to 2-4 days for traditional culture (Rapszky et al., eClinicalMedicine, 2025).
AI-Powered Predictive Analytics: Predictive models are increasingly being deployed to flag high-risk patients earlier, using lab data in combination with clinical records to accelerate intervention decisions before results are formally reported.
Cloud-Based EHR Integration: Direct result delivery into electronic health records eliminates manual transcription delays and ensures clinicians see critical values immediately. Labs that invest in seamless EHR connectivity will be better positioned as integrated care models become the standard.
Labs that invest in automation, optimized logistics, and real-time EHR integration will be better positioned for what comes next.
Conclusion: Prioritizing Speed Without Sacrificing Accuracy
Slow TATs carry real costs across patient care, operations, finances, and regulatory compliance. The evidence is consistent: faster results mean earlier treatment, shorter stays, fewer redundant tests, and better outcomes for patients and providers alike.
Healthcare providers need lab partners who deliver on both speed and accuracy. Nexus Medical Labs helps healthcare organizations improve diagnostic workflows, reduce turnaround times, and maintain the reliability their teams depend on. If your organization is looking for a lab partner that delivers, let’s talk.
